T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

10.1073/pnas.86.24.10024

10.1016/0092-8674(91)90314-O

10.1038/mt.2011.1

10.1182/blood-2010-01-043737

10.1182/blood.V71.1.13.13

10.1016/j.coi.2009.02.009

10.1038/mt.2009.83

10.1073/pnas.0813101106

10.1056/NEJMoa1103849

10.1182/blood.V85.6.1580.bloodjournal8561580

Ramsay A. G., Johnson A. J., Lee A. M., Gorgün G., Le Dieu R., Blum W., Byrd J. C., Gribben J. G., Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J. Clin. Invest. 118, 2427–2437 (2008).

Levine B. L., Bernstein W. B., Connors M., Craighead N., Lindsten T., Thompson C. B., June C. H., Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159, 5921–5930 (1997).

10.1158/0008-5472.CAN-10-0552

10.1158/1078-0432.CCR-06-1183

10.1200/JCO.2006.05.9964

10.1182/blood-2007-12-128843

10.1172/JCI46110

10.1084/jem.20060772

10.1189/jlb.0208107

10.1128/JVI.80.7.3532-3540.2006

10.1158/1078-0432.CCR-07-0674

10.1182/blood-2007-06-093906

10.1182/blood.V81.10.2658.2658

Bataille R., Jégo G., Robillard N., Barillé-Nion S., Harousseau J. L., Moreau P., Amiot M., Pellat-Deceunynck C., The phenotype of normal, reactive and malignant plasma cells. Identification of “many and multiple myelomas” and of new targets for myeloma therapy. Haematologica 91, 1234–1240 (2006).

10.1038/sj.mt.6300104

10.1038/nm.1882

10.1073/pnas.0608138103

10.1038/nm1310

10.1182/blood-2005-09-3716

10.1016/j.it.2007.06.001

10.1038/nri2216

10.1172/JCI40269

10.1371/journal.pone.0004749

10.1182/blood-2010-07-294520

10.1158/1078-0432.CCR-10-1280

10.1126/science.272.5259.263

10.1038/sj.gt.3302570

10.1038/mt.2009.16

10.1016/j.immuni.2009.09.007

10.1038/nbt0997-871

10.1182/blood-2003-01-0095